| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |